Watchdog orders Big Four to separate auditing units by 2024

first_imgHowever the government has not yet introduced legislation mandating change in the sector — partly due to Brexit and more recently, the coronavirus pandemic. “As part of the audit profession’s evolution, a holistic package of reforms, including improved director accountability and changes to the scope of audit, is required to deliver effective and sustainable change,” said Hywel Ball, chairman of EY UK. Sir Jon Thompson, chief executive of the FRC, said that operational separation of audit was a “major step in the reform of the audit sector”.  Watchdog orders Big Four to separate auditing units by 2024 Firms must submit an implementation plan to the FRC by 23 October this year, for implementation by June 30, 2024 at the latest, the regulator said. The Financial Reporting Council (FRC) is asking the companies to agree to operational separation by June 2024 to ensure their audits “do not rely on persistent cross subsidy from the rest of the firm”.  Stephen Griggs, Deputy chief executive at Deloitte UK, said: “We welcome this clarity from the FRC on the principles of operational separation and will continue working with them to develop our plans over the coming months.” Sector tainted by series of scandals Jon Holt, head of audit at KPMG UK, called for “an ambitious package of wider reforms across the corporate landscape,” including “clarifying and enhancing the responsibilities of boards, directors and management”. Read more: Accounting watchdog investigates London Capital & Finance audits All Big Four firms issued statements welcoming the watchdog’s announcement.  Before the Open newsletter: Start your day with the City View podcast and key market data The Big Four accounting firms — PwC, Deloitte, KPMG and EY — must separate their audit units from the rest of their businesses by 2024, the audit watchdog said this morning.  “The FRC remains fully committed to the broad suite of reform measures on corporate reporting and audit reform and will introduce further aspects of the reform package over time,” he added.  Auditors have come under increased regulatory scrutiny in recent years, with corporate failures at Carillion retailer BHS led to three government-backed reviews that recommended a shake-up of audit. center_img whatsapp whatsapp EY’s role in the collapse of Wirecard has also come under the microscope recently. The firm has been accused of failing to carry out standard audit procedure for three years at the disgraced German payments firm.  Show Comments ▼ (Getty Images) Read more: Head of audit review calls for urgent reform after Wirecard scandal Big Four back watchdog’s plans The FRC had already begun seeking voluntary changes to help speed up reform, and said on Monday it was asking the Big Four firms to agree to operational separation based on a set of principles it has already discussed with them. Anna Menin EY and KPMG both said they supported the FRC’s plans, but also called for changes to corporate governance in the UK in addition to audit reform.   Share More From Our Partners A ProPublica investigation has caused outrage in the U.S. this weekvaluewalk.comRussell Wilson, AOC among many voicing support for Naomi Osakacbsnews.comBiden received funds from top Russia lobbyist before Nord Stream 2 giveawaynypost.comAstounding Fossil Discovery in California After Man Looks Closelygoodnewsnetwork.orgConnecticut man dies after crashing Harley into live bearnypost.comNative American Tribe Gets Back Sacred Island Taken 160 Years Agogoodnewsnetwork.orgI blew off Adam Sandler 22 years ago — and it’s my biggest regretnypost.comPolice Capture Elusive Tiger Poacher After 20 Years of Pursuing the Huntergoodnewsnetwork.orgBrave 7-Year-old Boy Swims an Hour to Rescue His Dad and Little Sistergoodnewsnetwork.org Monday 6 July 2020 3:40 pm A PwC spokesperson said the firm “shares the FRC’s objectives of improved quality and confidence in audit” and “will continue to engage constructively” with the regulator.  last_img read more

Scottish broadcaster STV quadruples dividend for 2015 as profits rise

first_img by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeHealth Gut BoostRandy Jackson: This 3 Minute Routine Transformed My HealthHealth Gut BoostMoneyPailShe Was A Star, Now She Works In ScottsdaleMoneyPailMaternity WeekA Letter From The Devil Written By A Possessed Nun In 1676 Has Been TranslatedMaternity WeekMoguldom NationFather Of 2 Sues Los Angeles Hospital After Wife Dies During ChildbirthMoguldom NationGundry MD Bio Complete 3 SupplementTop Surgeon: This Simple Trick Empties Your Bowels Every Morning (Almost Immediately)Gundry MD Bio Complete 3 Supplementzenherald.com20 Rules Genghis Khan’s Army Had To Live Byzenherald.comForbesThese 10 Colleges Have Produced The Most Billionaire AlumniForbesMagellan TimesThis Is Why The Roy Rogers Museum Has Been Closed For GoodMagellan TimesHistory 10[Gallery] The 25 Worst Casting Choices of All-TimeHistory 10 Show Comments ▼ Scottish broadcaster STV quadruples dividend for 2015 as profits rise Read This Next’A Quiet Place Part II’ Sets Pandemic Record in Debut WeekendFamily ProofHiking Gadgets: Amazon Deals Perfect For Your Next AdventureFamily ProofIndian Spiced Vegetable Nuggets: Recipes Worth CookingFamily ProofAmazon roars for MGM’s lion, paying $8.45 billion for studio behind JamesFamily ProofCheese Crostini: Delicious Recipes Worth CookingFamily ProofHomemade Tomato Soup: Delicious Recipes Worth CookingFamily ProofWhat to Know About ‘Loki’ Ahead of Disney+ Premier on June 9Family ProofChicken Bao: Delicious Recipes Worth CookingFamily ProofBaked Sesame Salmon: Recipes Worth CookingFamily Proof whatsapp Scottish broadcaster STV yesterday posted a 14 per cent rise in profits for 2014, with a surprise quadrupling of its dividend, as its chief executive celebrated “the fruits of our work”.Revenues at STV, which holds the two ITV franchises for Scotland, increased seven per cent year-on-year to £120.4m, up from £112.1m in 2013, while profits hit £17.3m.The business, while sat under nearly £200m of debt in 2007, reported this had fallen a further 18 per cent last year to just £29.4m.“This is a company that has gone through a turnaround which I have led for eight years. These results are the fruits of our work,” chief executive Rob Woodward told City A.M.“STV full-year 2014 results were in line with expectations but the company surprised on its dividend announcement with a higher than expected payout,” wrote Liberum analyst Ian Whittaker who held a target price of 440p on the stock.“The positive surprise is on the dividend, which has quadrupled to 8p [we had 6p] and are targeting 10p for 2015 [we have 8p currently].”Shares in the group rose 1.88 per cent following the results to close at 380p in London. center_img Express KCS Tags: NULL whatsapp Thursday 26 February 2015 9:10 pm Sharelast_img read more

Tower Hamlets rejects British Land’s major Shoreditch Estate development in Norton Folgate

first_imgTower Hamlets has rejected planning permission for a major new development put forward by British Land.  The council threw out proposals for the Norton Folgate scheme, otherwise known as the Shoreditch Estate, during last night’s strategic development committee.  Had it been successful, the development would have comprised 320,000 sq ft of office, residential and retail floor space. British Land acquired the land from City of London two years ago.  But the development has been controversial with locals who are concerned about the demolition of  historic buildings that it would necessitate. Last weekend campaigners joined hands around the neighbourhood to protest against the move.  Another concern was that the office space would only be used for one, corporate tenant, pricing local people out of the area. A spokesman told City A.M.: “Last night at the strategic development committee, the committee resolved not to follow the officers’ recommendation to approve the Norton Folgate planning application.  “The committee raised concerns around the impact that this would have on the historic buildings and the conservation area. They also expressed concern around the general level of housing as well as affordable housing in the planning proposals.” British Land added in a statement: “We are disappointed the planning committee didn’t recognise the considerable merits of our scheme. We are now considering our options.”  It is unclear what will happen to the property if it is no longer able to be developed and if it effectively becomes a white elephant for British Land; either way, the property firm is now back in talks with City of London.  A City of London spokesman confirmed: “We’re aware that British Land are considering their options and are in discussions with the company.”  Share Tags: British Land Co Company Video Carousel – cityam_native_carousel – 426 00:00/00:50 LIVERead More Show Comments ▼ Ad Unmute by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeGameday NewsNASCAR Drivers Salaries Finally ReleasedGameday NewsUndoSwift VerdictChrissy Metz, 39, Shows Off Massive Weight Loss In Fierce New PhotoSwift VerdictUndoMaternity WeekA Letter From The Devil Written By A Possessed Nun In 1676 Has Been TranslatedMaternity WeekUndoPost FunKate & Meghan Are Very Different Mothers, These Photos Prove ItPost FunUndozenherald.comMeghan Markle Changed This Major Detail On Archies Birth Certificatezenherald.comUndoEquity MirrorThey Drained Niagara Falls — They Weren’t Prepared For This Sickening DiscoveryEquity MirrorUndoTheFashionBallAlica Schmidt Is The Most Beautiful Athlete To ExistTheFashionBallUndoLearn It WiseAfter Losing 70lbs Susan Boyle Is So Skinny Now She Looks Like A ModelLearn It WiseUndoEliteSinglesThe Dating Site for Highly-Educated Singles in ScottsdaleEliteSinglesUndo Catherine Neilan Tower Hamlets rejects British Land’s major Shoreditch Estate development in Norton Folgate Wednesday 22 July 2015 8:25 am whatsapp More From Our Partners Institutional Investors Turn To Options to Bet Against AMCvaluewalk.comUK teen died on school trip after teachers allegedly refused her pleasnypost.comPolice Capture Elusive Tiger Poacher After 20 Years of Pursuing the Huntergoodnewsnetwork.orgKiller drone ‘hunted down a human target’ without being told tonypost.comBrave 7-Year-old Boy Swims an Hour to Rescue His Dad and Little Sistergoodnewsnetwork.orgWhite House Again Downplays Fourth Possible Coronvirus Checkvaluewalk.comAstounding Fossil Discovery in California After Man Looks Closelygoodnewsnetwork.orgRussell Wilson, AOC among many voicing support for Naomi Osakacbsnews.comNative American Tribe Gets Back Sacred Island Taken 160 Years Agogoodnewsnetwork.orgFlorida woman allegedly crashes children’s birthday party, rapes teennypost.comSupermodel Anne Vyalitsyna claims income drop, pushes for child supportnypost.comI blew off Adam Sandler 22 years ago — and it’s my biggest regretnypost.com‘Neighbor from hell’ faces new charges after scaring off home buyersnypost.comMatt Gaetz swindled by ‘malicious actors’ in $155K boat sale boondogglenypost.com‘The Love Boat’ captain Gavin MacLeod dies at 90nypost.comWhy people are finding dryer sheets in their mailboxesnypost.comPuffer fish snaps a selfie with lucky divernypost.comInside Ashton Kutcher and Mila Kunis’ not-so-average farmhouse estatenypost.com whatsapplast_img read more

People / ‘A good choice’ – TIACA unveils new secretary general Vladimir Zubkov

first_img Speculation over who will be the next secretary general of TIACA has ended with the announcement that Vladimir Zubkov will take over from Doug Brittin in January.Vice president of Volga-Dnepr Group Mr Zubkov, who has been a member of TIACA’s board since 2011 and has more than 20 years’ experience at ICAO, has been welcomed.“He is very competent and I think genuinely nice,” said one senior insider. “He is a good presenter and seems to understand the business well.“The only issue I see is turning from being a board member to secretary general. How will the board see him? How will he see the board?  But all in all, I think he is a good choice.” Mr Zubkov has plenty of industry body experience – he is chairman of TIACA’s Industry Affairs Committee and a member of the Global Air Cargo Advisory Group and IATA Industry Affairs Committee.One senior air cargo executive said it would be good for TIACA to take a different direction under his helm.“He is a reasonable choice, and at least he brings something other than TSA knowledge. Just pushing US-centric issues such as TSA has damaged TIACA’s credibility.“Training and recruitment, e-commence and transparency have all been ignored and these are the real concerns, as well as belly versus freighters and how to address low yields caused by overcapacity.”Other concerns at TIACA are over its weakened financial state. While past secretary general Daniel Fernandez was known for his commercial abilities and the financial success of the association’s main event, the Air Cargo Forum, in recent years TIACA has turned its attention more to industry affairs.This has led, according to some sources, to a fragile financial condition.The insider said: “It seemed to me that TIACA needed a guy with conference experience to make ACF a success. Vladimir’s role inside VD was more corporate, so I am not sure what real commercial experience he has.”However, last year’s appointment of Warren Jones as director for membership and sales removes some commercial responsibility from the secretary general’s plate.“Between him and Warren, it should be ok,” said a source. “The finances of TIACA are related to the industry’s perception of its relevance.”Mr Zubkov promised to respond to questions from The Loadstar later today, but in a press statement said about his role: “We recognise that TIACA needs to grow its engagement in territories where it is under-represented, such as the Far and Middle East, Latin America and Africa, and we will focus on recruiting more members in those areas.“We must also continue to push for the modernisation of the industry, championing e-commerce and e-freight penetration and talking convincingly to the World Trade Organization, the United Nations Conference on Trade and Development (UNCTAD), regional development banks and relevant regional organisations to form new alliances in order to drive faster and more complete adoption of e-freight.” By Alex Lennane 16/11/2016last_img read more

Scientists work toward an elusive dream: a simple pill to treat Covid-19

first_img @damiangarde By Damian Garde April 9, 2021 Reprints About the Author Reprints National Biotech Reporter Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host of “The Readout LOUD” podcast. “We need to start thinking about biomedical research as essential infrastructure,” said Angela Rasmussen, a virologist at Georgetown University’s Center for Global Health Science and Security. “It reinforces that preparedness is not just about how prepared we are to innovate our way out of a crisis. It really does mean investing in drugs that may not have an obvious application when we’re developing them up front.”How to make an antiviralThe fundamental problem, for drug hunters, is that viruses don’t fight fair.As soon as SARS-CoV-2 takes hold, it begins using the body’s natural machinery to replicate itself. That gives the virus an edge. Scientists might spot scores of vulnerabilities in a virus, but the majority of them are sure to be shared by the host, making them unsafe targets to attack with a drug.“If you look at the number of antivirals that exist compared to the number of antibiotics, there are so many fewer antivirals,” said Brianne Barker, a biology professor at Drew University who specializes in the body’s response to viral infection. “The reason for that is that viruses use our cells to reproduce, so you’re looking for a drug that hits some part of the viral reproduction without hurting our cells. And that’s not easy.”Step one in the antiviral-development process is clearing that hurdle again and again, in the lab, in animals, and in healthy human volunteers.The next challenge relates to timing. The precise moment of viral infection starts a countdown clock as the virus gradually awakens the immune system, creating a narrow window of time after which an antiviral is likely useless.“For most viral diseases, the acute ones, the disease is really caused by the host’s response to it,” Rasmussen said. “If that virus gets a foothold and sets off all of these abnormal host processes, the horse is already out of the barn, so to speak.”For SARS-CoV-2, it can take anywhere from a few days to two weeks for those abnormal immune processes to kick in. That means any clinical trial for an antiviral requires a delicate design. Patients must have confirmed infections, but if they’re already experiencing serious symptoms of Covid-19, they might be too far along to benefit.Once a would-be antiviral developer has solved the timing problem, then there’s the conundrum of choosing a dose. In normal circumstances, dosing is a precise science, studied in tiered, escalating studies designed to isolate the perfect amount of drug that can achieve a benefit at minimal risk.In the immediacy of the pandemic, drug developers have understandably sped past some of that methodical work, making educated guesses in the spirit of emergency. That makes each antiviral trial a high-wire scientific act, said Craig Rayner, an executive at the drug development consultancy Certara who worked on Tamiflu. Choosing the right dose can determine not only whether a trial will succeed, but also the manufacturing, rollout, and final cost of the drug in question.“For every milligram above what is considered optimal, you’re wasting it,” Rayner said. “And for every milligram below, you’re putting everything at risk, because the virus has a chance to be clever and evolve around it.”That leads to the next hurdle in developing antivirals: Even if you succeed, one drug is never enough. Unless a given antiviral can block 100% of viral replication, in time, evolution is going to kick in.“In any other aspect of pharma, you’d never need to have 100% efficacy,” Barker said. “But with antivirals, if you allow any replication at all, the virus is going to mutate around the drug.”In the long-term, the best bet for controlling SARS-CoV-2 is widespread vaccination backed up by a combination antiviral treatment, experts said — a drug cocktail that targets multiple facets of the virus to minimize the risk of mutation.But first, they need that Tamiflu.The leading contendersThe first drug poised to check all the boxes of an ideal antiviral is molnupiravir, invented at the Emory Institute for Drug Development and developed by Merck and Ridgeback Biotherapeutics. The drug is what’s known as a nucleoside analog, designed to throw a wrench in the process of viral replication by tricking SARS-CoV-2 into corrupting its own genetic material.Merck is enrolling about 3,000 patients, both hospitalized and not, in a Phase 2/3 trial that will determine whether molnupiravir can help clear SARS-CoV-2 from the body faster than placebo and keep patients out of the hospital. Data from the smaller Phase 2 portion are expected in the coming weeks, and experts are particularly focused on whether Merck’s drug can prevent patients with mild symptoms from developing severe Covid-19.Behind Merck’s drug is a treatment from Atea Pharmaceuticals that builds on prior antiviral success. Atea’s drug, AT-527, targets an enzyme key to viral replication, a similar approach to Gilead Sciences’ curative treatments for hepatitis C. Later this year, Atea expects to have Phase 2 data on AT-527’s benefits for patients in and out of the hospital. The company is also planning a larger, Phase 3 study on outpatients.Experts are hopeful that both drugs can make a difference. They’ve selected targets that are likely to minimize the risk of side effects, and they’ve designed studies that should determine whether they work in that key post-diagnosis window. However, some expressed concern that because neither treatment was specifically engineered for SARS-CoV-2, there remains a substantial risk that each will come up short. When it comes to repurposed antivirals, “theoretically they should work great,” Rasmussen said, “but in reality a lot of times they don’t.”An antiviral from Pfizer, now in the earliest stages of human testing, could address that problem. Catchily named PF-07321332, Pfizer’s drug targets SARS-CoV-2’s backbone enzyme, the linchpin of the virus’s replication process. That enzyme, called 3CL, is one of two that are specific to all coronaviruses. That means if Pfizer can find the right dose, and run the right trials, it might have a treatment not just for SARS-CoV-2 but future pandemic viruses.“What we might end up doing here is curing the common cold,” Collins said. “Then I wouldn’t have to listen to those jokes anymore.” Privacy Policy As simple as that sounds, the process of actually developing new antiviral treatments is overwhelmingly complicated, even outside of a pandemic. Things can go disastrously wrong at countless steps along the way, whether drugs are too weak to stop the viral spread or too sloppy to be safe. And SARS-CoV-2 is consistently evolving, meaning scientists have to outfox natural selection itself to stay ahead of the game.The common cold is often caused by a coronavirus, after all. And, as scientists ruefully joke, after billions of dollars spent on research and development, there’s still no cure for that.advertisement [email protected] Leave this field empty if you’re human: But in the case of Covid-19, it’s not for lack of trying. While the breathless search for a Covid-19 vaccine got most of the attention, the National Institutes of Health was running a sweeping parallel effort to find treatments for the disease itself.Some drugs ended up being dead ends, like the malaria drug hydroxychloroquine, and some were unexpected successes, like the lifesaving steroid dexamethasone. Among the bright spots was Gilead Sciences’ remdesivir, an intravenous antiviral that proved to modestly reduce the length of hospitalization for patients with Covid-19. Likewise the antibody treatments from Eli Lilly and Regeneron, which helped keep high-risk patients out of the hospital.Still missing, however, is what NIH Director Francis Collins called his “dream”: a highly effective pill that can be given immediately after diagnosis.“It’s just a damn long pathway,” Collins said in an interview. First scientists have to find molecular vulnerability in a virus, and then comes the process of screening hundreds of thousands of would-be drugs to find the few that latch onto that target. Then medicinal chemists get to work on honing a Goldilocks molecule that balances power, specificity, and safety, and if everything goes well in the Petri dish, there’s still months of animal testing to do before a single human being can take a pill in a clinical trial.“But I will tell you that this is an extremely high priority for Tony Fauci and Francis Collins and the Biden administration, to work with these companies to try to make sure that we speed this up,” Collins said. “Because this pandemic is going to be with us — even with great vaccines — and people are going to get sick.”There is hope, even in the short term. Any day now, Merck is expected to present pivotal data on an oral treatment akin to remdesivir. Behind that is a treatment from Atea Pharmaceuticals, first developed for hepatitis C virus, which could have pivotal results in the coming months. Neither is purpose-built for the virus that causes Covid-19, but experts said the treatments could still tick many of the boxes of a hoped-for antiviral.Perhaps most promising is a novel antiviral from Pfizer, a drug engineered specifically for the virus SARS-CoV-2 that entered its first clinical trial last month.Scientists are crossing their fingers that each one demonstrates at least a marginal benefit, as the history of virology suggests the best bet for beating back Covid-19 will be a cocktail of treatments with complementary effects. But beyond the immediate crisis, experts hope society learns two key lessons: Antiviral development is really hard, and it’s even harder if you wait for a pandemic to start investing in it. The world has vaccines that can prevent most cases of Covid-19. It even has drugs that can help with the most serious symptoms of the disease. Now what it needs is a Tamiflu for SARS-CoV-2.It would be a pill, exquisitely calibrated to target SARS-CoV-2, with tolerable side effects and a low price tag. And it would work just as well as those antibody treatments that require an hourlong intravenous infusion, but it would come in a handy packet patients could take home.“We’re looking for something I could give everyone in an urgent care setting who comes in with exposure or a positive test,” said Nathaniel Erdmann, an infectious disease specialist at the University of Alabama at Birmingham Hospital who treats Covid-19. “An easy, oral, safe drug.”advertisementcenter_img HealthScientists work toward an elusive dream: a simple pill to treat Covid-19 Adobe Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson Please enter a valid email address. Newsletters Sign up for Daily Recap A roundup of STAT’s top stories of the day. Damian Garde Related: Tags Coronaviruslast_img read more

Big changes to OSC’s independent Investor Advisory Panel

first_img Retail trading surge on regulators’ radar, Vingoe says NASAA approves model act for establishing restitution funds Related news OSC finalizes DSC ban BMO GAM’s Ross Kappele elected IFIC chairman The list of newcomers to the IAP announced on Monday, which comes at a time when regulators are contemplating critical investor protection reforms, includes: > Neil Gross, who stepped down as executive director of the Canadian Foundation for Advancement of Investor Rights (FAIR Canada) last autumn and now works as a public policy consultant. > Malcolm Heins, chairman of the Ontario government appointed Expert Committee to Consider Financial Advisory and Financial Planning Policy Alternatives, which is recommending the adoption of a best interest duty in Ontario. > Paul Bates, a lawyer with Siskinds LLP, who has a diverse legal practice concentrating on complex commercial litigation, including securities litigation and claims against financial advisors and portfolio managers. Gross, Heins and Bates will replace well-known outgoing IAP members, including vocal investor advocate Ken Kivenko; securities lawyer Harold Geller; and former regulator and one-time IAP chairwoman Connie Craddock. The IAP’s most recent chairwoman, Ursula Menke, is also leaving, as is Alison Knight. Letty Dewar — former investment industry executive and one of two continuing IAP members, along with former advisor Louise Tardif — has replaced Menke as chairwoman. Dewar has served on the IAP since 2014 and took over her current role effective June 1. Heins officially joined the panel on Monday along with two other new members: long-time financial services executive, Jacqueline Allen, who was most recently head of portfolio and electronic trading sales at Bank of America Merrill Lynch Canada; and Larry Bates, an expert on fixed-income markets. Paul Bates, Gross and two more new members — veteran fund industry executive Patti Best and Harvey Naglie, former senior policy advisor with the Ontario Ministry of Finance — will each start two-year terms on Nov. 1. The IAP’s membership makeover comes at a critical time for investor advocates as regulators are currently contemplating major policy decisions, including a possible ban on embedded commissions and plans for a best interest standard in Ontario, along with a series of other reforms to retail regulation. Photo copyright: sophiejames/123RF Keywords Investor protectionCompanies Ontario Securities Commission James Langton Share this article and your comments with peers on social media The Ontario Securities Commission’s (OSC) Investor Advisory Panel (IAP) is undergoing a sweeping change in its membership that sees seven new members appointed to the independent panel during the coming year. Facebook LinkedIn Twitterlast_img read more

First wave of targeted Tier 3 community testing initiatives announced

first_imgFirst wave of targeted Tier 3 community testing initiatives announced First 67 local authorities confirmed to start community testing programmes as part of government’s COVID-19 Winter PlanMore than 1.6 million rapid-turnaround lateral flow tests will be immediately deployed to detect asymptomatic cases and drive down transmission in highest risk areasOver 100 local authorities are expected to run programmes in the new yearTaken together with existing restrictions, community testing will help put Tier 3 areas on a route out of toughest restrictionsThe first wave of Tier 3 areas to receive the government’s community testing offer have been confirmed today. When combined with existing measures, this will help put Tier 3 areas on a route out of the toughest restrictions.Over 100 local authorities are engaged in the community testing programme with more rollouts due to begin in the new year.Roughly one in three people have the virus without symptoms so could be spreading the disease without knowing it. Broadening testing to identify those showing no symptoms will mean finding positive cases more quickly, and break chains of transmission.With its targeted approach, community testing aims to reduce the prevalence of the virus in the highest risk areas. Based on their in-depth knowledge of their local community, local authorities have created community testing plans, taking into account detailed prevalence data and demographics.These include:Oldham will start increasing access to rapid testing for coronavirus. The initial plan will focus on those communities most significantly affected by the virus, higher risk supported living settings, health and social care staff, schools and colleges.Lancashire plans to start testing with large manufacturing sites, and businesses with workforces greater than 200, as well as more vulnerable groups.Kirklees plans to undertake whole borough community testing starting in areas of persistently high infection rates and targeting high risk workplaces.More than 1.6 million lateral flow tests will be immediately delivered for use in December with many more to follow.Government support will be provided to support community testing programmes for a minimum of 6 weeks, with more Tier 3 local authorities due to join the community testing offer over the coming weeks and into 2021.Health and Social Care Secretary Matt Hancock said:I am really pleased to announce the first areas embarking on enhanced community testing programmes – after the successful work in Liverpool. With one in three people with coronavirus showing no symptoms, increased community testing is a vital additional tool at our disposal to help identify those who are infected and infectious, but unaware that they might be spreading the disease.Community testing will be very important in helping the areas where levels of the virus are highest to drive down infection rates and ultimately will help areas ease tougher restrictions.This is just the start, and we are working quickly to roll out community testing more widely as soon as more local teams are ready. I urge all those living in areas where community testing is offered to come forward and get tested.General Sir Gordon Messenger, Chief of Operations, said:We want to extend our thanks to the more than 100 local authorities who have engaged so quickly and comprehensively, allowing us to take forward the first stage of the community testing programme, and our operational team will begin to roll these out from as early as next week.We continue to work extensively with Local Authorities on their proposals to expand the programme to more areas over the coming weeks and months, increasing testing services available to communities.Local authorities can bid for this additional testing and support capability on an ongoing basis, enabling them to create a bespoke testing programme for their community, using a model of local delivery supported by central resource.Community testing builds on the nearly 1.5 million lateral flow test kits which have already been delivered to 90 local authorities across all levels of tier restrictions to date, through the Directors of Public Health programme. Extensive clinical evaluation has been carried out on the lateral flow tests by Public Health England and the University of Oxford which show these tests are accurate and sensitive enough to be used in the community.Asymptomatic testing works hand in hand with the existing PCR testing service for those with COVID-19 symptoms as part of the comprehensive NHS Test and Trace testing offer. With over 700 test centres across the country, including 79 drive-through sites, 386 local test sites, 20 satellite test sites, 258 mobile testing units, and home testing, the average distance a person travels to visit a test site is now just 2.3 miles.The government’s COVID-19 Winter Plan sets out ambitious steps to drive down transmission of the virus, reduce its prevalence and so reduce the number of deaths and serious illnesses. Alongside the vaccine rollout which has now begun, tiering restrictions, and investment in NHS capacity, continued developments in our testing programme make it possible to reduce cases in the areas where the need is greatest.Background informationThe list of LAs that have submitted proposals and have an ambition to begin testing in December are listed below.The community testing offer remains open to all LAs in Tier 3.List of local authoritiesAmber ValleyBolsoverChesterfieldDerbyshire DalesNorth East DerbyshireSouth DerbyshireDarlingtonStockton on TeesAshfordCanterburyDartfordDoverFolkestone and HytheGraveshamMaidstoneSevenoaksSwaleThanetTonbridge and MallingTunbridge WellsMedwayBlackburn with DarwenBlackpoolBurnleyChorleyFyldeHyndburnLancasterPendlePrestonRibble ValleyRossendaleSouth RibbleWest LancashireWyreBoltonBuryManchesterOldhamRochdaleSalfordStockportTamesideTraffordWiganBarnsleyBradfordKirkleesBirminghamDudleySandwellCannock ChaseEast StaffordshireLichfieldNewcastle-under-LymeSouth StaffordshireStaffordStaffordshire MoorlandsTamworthStoke-on-TrentNorth WarwickshireNuneaton and BedworthRugbyStratford-on-AvonWarwickWolverhamptonSolihullDecision on local authorities selected to receive support immediately to start community testing based on the local infection rate, readiness of their plans, and other logistical and commercial considerations to ensure testing delivers the best possible value for money.Anyone with one or more of these symptoms – a high temperature, a new, continuous cough, or a loss or change to sense of smell or taste – should book a test at nhs.uk/coronavirus or by calling 119. /Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here. Why?Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don’t put up a paywall – we believe in free access to information of public interest. Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more hereWe endeavour to provide the community with real-time access to true unfiltered news firsthand from primary sources. It is a bumpy road with all sorties of difficulties. We can only achieve this goal together. Our website is open to any citizen journalists and organizations who want to contribute, publish high-quality insights or send media releases to improve public access to impartial information. You and we have the right to know, learn, read, hear what and how we deem appropriate.Your support is greatly appreciated. All donations are kept completely private and confidential.Thank you in advance!Tags:Canterbury, community, coronavirus, Darlington, Government, infection, Investment, Lancaster, liverpool, Messenger, Moorlands, public health, satellite, Secretary, UK, UK Government, university, University of Oxfordlast_img read more

Lodi Winegrape Commission Celebrates 30 Years, Passing Referendum with 85% Approval

first_imgPinterest Linkedin TAGSLodi American Viticultural AreaLodi Winegrape Commission Twitter Previous articleHospitality Industry Veteran Michael Ploetz Joins Tamber Bey VineyardsNext articleTwo Rare Bottles of Wine from Hungary’s Famous Tokaj Wine Region to be Offered at Auction Press Release Facebook Email Home Industry News Releases Lodi Winegrape Commission Celebrates 30 Years, Passing Referendum with 85% ApprovalIndustry News ReleasesWine BusinessLodi Winegrape Commission Celebrates 30 Years, Passing Referendum with 85% ApprovalBy Press Release – June 1, 2021 182 0 AdvertisementOrganization’s success attributed to support and funding by visionary winegrowersLODI, Calif., June 1, 2021 – The California Department of Food & Agriculture (CDFA) announced last week that the Lodi Winegrape Commission referendum passed with 85% of the region’s growers voting in favor of continuation. This news comes at the 30th anniversary of the organization.Established in 1991 as the grower-centric force behind the Lodi American Viticultural Area (AVA), the California-based organization represents 750 winegrowers farming more than 100,000 acres of winegrapes. Over the years, the Commission has provided abundant support for the region through marketing, education, research, and sustainable winegrowing programs, cementing Lodi’s leadership in viticulture and elevating its reputation as a premium winegrowing region. To sustain its objectives, the Commission collects an annual assessment of gross value of the winegrape crop. Every five years, local growers vote on the continuation of the organization and its programs.The past 30 years have seen the Commission excel at its objectives including the enhancement of awareness and recognition of the region among core buyers and consumers as well as trade and media. Proof of the organization’s decades-long work is reflected in the region itself. Since 1991, Lodi’s acreage under vine has more than doubled, progressing from 39,000 acres to over 100,000 acres. Crop values have followed suit, increasing from $80 million to more than $500 million, and the number of wineries has expanded exponentially from six to 85. Wine-related tourism continues to generate billions of dollars in annual economic impact for the community. Most importantly, the recognized Lodi Appellation has become an indicator of quality on labeled wines which have grown from a modest handful in the early 1990s to thousands today.Reflecting on the Commission’s success, current chair of the Lodi Winegrape Commission, Kendra Altnow says, “Much, including our farming practices, has changed since 1991 but one fact remains unwavering: we continue to work together as a community of growers; our collaboration benefitting our appellation as well as ourselves as individuals.” Altnow’s father, Brad Lange of LangeTwins Family Winery & Vineyards, served as the Commission’s first chair 30 years ago.Among the most impactful achievements of the Lodi Winegrape Commission over the past 30 years in terms of driving recognition and awareness are its programs in regional marketing. In 2012, the highly visible and successful consumer-facing branding and national marketing campaign, LoCA – The Wines of Lodi, California, favorably positioned the region as one filled with authentic, approachable winegrowers who are fanatical about producing high quality grapes and wines. Efforts of the campaign paid off in 2015 when Lodi was honored as Wine Enthusiast Magazine’s Wine Region of the Year. As the area has evolved, so has its marketing. In January 2020, the Commission revealed elevated Lodi Wine brand identities for the region as well as its growers and its organization. The accompanying marketing campaign – There’s Something Happening Here – calls its audience to discover Lodi’s growers and producers along with its distinct soils, micro-climates, and diversity of winegrape varieties through stories, illustrations, and traditional imagery.In October 2020, the Commission launched Save the Old Vines – a marketing campaign aimed specifically at the preservation of heritage vineyards. The campaign experienced tremendous success, generating 2.7 million ad views and nearly 10,000 website visits plus $20,000 in revenue from sales of old vine wines and merchandise.  In addition to national coverage from Wine Enthusiast, the campaign earned international attention from British wine critic and writer Jancis Robinson as well as educators and viticulturalists tied to the cause. In March, the Commission was one of a handful of leaders asked to speak at the world’s first Old Vine Conference – a movement dedicated to ensuring heritage vineyards a valued and enduring place within the commercial realities of the global wine industry.“Lodi has always had what it takes to be a phenomenal winegrowing region,” says Stuart Spencer, Executive Director of the Lodi Winegrape Commission. “We have the right soils and micro-climates; most importantly, we have the right people. I’ve been a part of this industry since I was a child and I’ve seen a lot. One thing I have not seen anywhere else is a community of growers and producers who are willing to put a region before individual businesses. Selfless collaboration is where Lodi’s greatest success lies.” Spencer has served the Commission since 1999.Another significant achievement of the Commission is the creation of the LODI RULES for Sustainable Winegrowing program in 2005. Launched in 1992 as a grassroots education program, LODI RULES is widely regarded as the most comprehensive and rigorous sustainable vineyard certification in the world and continues to serve as the inspiration and basis for numerous other programs. What began as a handful of certified vineyards in 2005 has, today, increased to nearly 1,300 certified vineyards and 55,380 certified acres across 16 California Crush Districts, Washington, and Israel. Revenue from growers utilizing the certification program outside of Lodi brought in nearly $55,000 to the Commission in 2020.Over the years, LODI RULES has received considerable recognition including receipt of the Governor’s Environmental and Economic Leadership Award (GEELA) in 2006 and again in 2014. Regularly reviewed by academics, scientists, and viticulturists, the progressive program continues to remain at the forefront of sustainability innovation. Recently, the program underwent a thorough revision and in 2022, twenty new standards will be added to the current list of more than 100. Also in 2020, LODI RULES was translated into Spanish, extending the educational impact and value of the program.In addition to its programs in marketing and sustainable viticulture, the Commission’s leadership in research and education continues to spur innovation in technology, viticultural practices, and modern thinking among its growers and industry at large. In August 2020, the Commission released “Mealybug Biocontrol in California Vineyards”– an eight-minute video detailing a one-year project with Dr. Kent Daane and a team of Lodi growers to demonstrate insect release and pheromone mating disruption for mealybug biocontrol in California vineyards. The project was part of a $50,000 Professional + Producer Western SARE grant, awarded in 2019. In December 2020, this grant project was leveraged into a larger project – a $1 million BIFS (Biologically Integrated Farming Systems) grant awarded to Dr. Kent Daane – to study mealybug biocontrol in Lodi and on the Central Coast.Earlier in 2020, collaboration and funding by the Commission, American Vineyard Foundation, and CDFA PD/GWSS Board resulted in the publication of a 138-page book titled “What Every Winegrower Should Know: Viruses.” Developed between members of the Lodi Grapevine Virus Research Focus Group led by Dr. Stephanie Bolton of the Lodi Winegrape Commission and experts, the comprehensive guide addresses grapevine virus basics, mealybugs, virus testing and spread, sudden vine collapse, and others. More than 700 copies have been distributed across California, to several US states, and internationally.The Commission will soon further expand its leadership and impact in grapevine research by adding a dedicated viticulture research specialist to its small staff. This position will allow the Commission to conduct on-farm vineyard trials benefitting its growers and broader industry. Asks Altnow, “So, what does the next 30 years for the Lodi Winegrape Commission look like? Like the last three decades, only time will tell but I believe we are on the right path. With a strategic plan to guide us, we are committed to taking innovative approaches to marketing and expanding practical research, education, and outreach – all with the goal of helping ourselves to succeed.”Other notable achievements of the Commission over the past 30 years include:In 1998, the Lodi Winegrape Commission partners with the City of Lodi to establish the Lodi Conference & Visitor’s Bureau.In 2000, the Lodi Winegrape Commission establishes the Lodi Wine Visitor Center – one of the industry’s original regional wine education and tasting centers. In 2006, the Lodi Winegrape Commission is instrumental in establishing seven unique areas or nested AVAs within the greater Lodi AVA: Alta Mesa, Borden Ranch, Clements Hills, Cosumnes River, Jahant, Mokelumne River, and Sloughhouse. In 2020, the Lodi Winegrape Commission launches The Modern Farmer Series – a hands-on, grower education series aimed at profitability and marketing. About the Lodi Winegrape CommissionEstablished in 1991, the Lodi Winegrape Commission represents the common interests of Lodi winegrowers with programs in marketing, education, research, and sustainable viticulture.  The Commission collectively and effectively promotes Lodi’s vibrant, multi-generational farming community and California’s most dynamic wine region. Comprised of nine commissioners and nine alternates, the board of directors provides direction and input on behalf of the region’s 750 winegrowers. For more information about the Lodi Winegrape Commission, visit lodigrowers.com. About the Lodi American Viticultural Area (AVA)A historic winegrowing region since the 1850s, Lodi is perfectly situated 40 miles south of Sacramento and 90 miles east of San Francisco. Lodi’s Mediterranean climate and distinct soils allow its growers to cultivate 125 winegrape varieties, making Lodi the most diverse winegrowing region in the United States. The region also serves as home to 85 boutique wineries specializing in small-lot, handmade wines that have garnered major awards at domestic and international wine competitions. Lodi is naturally a leader in sustainable viticulture. Created by California farmers and accredited by world-renowned scientists, LODI RULES is America’s original sustainable winegrowing program. Held to a high standard of scientific rigor and excellence, the program emphasizes environmentally and socially responsible practices, while keeping economic feasibility in mind for long-term business success. Today, there are more than 55,000 acres certified throughout California, in Washington, and Israel. For more information about the Lodi AVA or LODI RULES, visit lodiwine.com and lodirules.org.Advertisement ReddIt Sharelast_img read more

PD Hinduja Hospital & MRC observes World Patient Safety Day

first_img News Menopause to become the next game-changer in global femtech solutions industry by 2025 Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app The hospital building was lit up in orange colour to show their commitment to the safety of patientsOn the occasion of World Patient Safety Day, PD Hinduja Hospital & Medical Research Centre, Mahim, recently conducted awareness programmes. The initiative reached out to a maximum number of people to create awareness about prioritising patient safety as a global health priority to urge people and healthcare professionals to show their commitment towards making healthcare safer.As a part of the initiative, Dr Anjali Shetty, Consultant Microbiologist and Dr Rishi Kumar, Consultant General Medicine alongside the trained hospital staff conducted sessions on ‘Rational Use of Antibiotics’ and ‘CPR Training.’ These sessions were conducted in partnership with the patients to spread awareness on a patient safety culture.Following the WHO global Theme this year, PD Hinduja Hospital building was lit up in orange colour to show their commitment to the safety of patients. This year, the global theme for World Patient Safety day focuses on spreading awareness following an orange theme.Apart from hosting orientation programmes, PD Hinduja Hospital took an initiative to promote ‘World Safety Patient Day’ with Boffin a mascot handing over handouts with a small distribution kit containing hand wipes, mask, and a sanitizer to drive safety measures educating people around the topic ‘Be our Patient Safety Partner’ outside the hospital.Joy Chakraborthy, COO, PD Hinduja Hospital & MRC said, “There is a need to create awareness amongst patients about seeking medical help and making decisions about the management of minor diseases. Patient safety is our ultimate goal and we are happy to be part of this initiative adopted by WHO on the very first World Patient Safety Day. Individuals today self-medicate themselves. It is associated with risks such as misdiagnosis, use of excessive drug dosage, prolonged duration of use and drug interactions. Hence, monitoring systems and building a partnership between patients, physicians and pharmacists and the provision of education and information to all concerned on safe self-medication maximise benefits and minimise risk”. WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Dr Anjali ShettyPD Hinduja Hospital & Medical Research CentreWHOWorld Patient Safety Day Phoenix Business Consulting invests in telehealth platform Healpha Share Related Posts Comments (0) Read Article By EH News Bureau on September 19, 2019 Add Comment PD Hinduja Hospital & MRC observes World Patient Safety Day The missing informal workers in India’s vaccine storylast_img read more

UWI to Forge Stronger Links With American Universities

first_imgFacebookTwitterWhatsAppEmail WASHINGTON, D.C — The Mona School of Business and Management (MSBM) at the University of the West Indies (UWI) is moving to forge stronger links with the Business Schools of Howard University, and the American University, which are based in the United States capital, Washington, D.C. A four-man delegation, headed by Pro-Vice Chancellor and UWI Mona Campus Principal, Professor Gordon Shirley, visited Washington, D.C. recently for meetings with officials of both tertiary institutions. The team included: Dean of the Faculty of Social Sciences, Professor Edward Duggan; MSBM Executive Director, Professor Paul Simmons, and Deputy Executive Director, Dr. Denzil Williams.  The UWI officials’ trip was a return visit to one made earlier this year by the Deans of Howard and the American Universities, Drs. Barron Harvey and Michael Ginzberg, respectively, for meetings with their local counterparts. The meetings in Jamaica and the United States were organized and facilitated by Advisory Board member of Howard and American Universities’ Business Schools, George Willie, a UWI alumnus. Mr. Willie is a principal and managing partner in one of the largest accounting and management consultancy firms in Washington, D.C., Bert Smith and Company. Speaking at a reception, hosted for the Jamaican delegation by Mr. Willie, at the City Club in Washington Square, Professor Shirley pointed out that the UWI and both American colleges “share similar interests”, and have been collaborating on how best to strengthen linkages between their business schools. Professor Shirley noted Mr. Willie’s longstanding interest in establishing a strong accounting programme in Jamaica that could be linked to a number of international bodies. “We have started to talk about how he can leverage his connections here to help us to establish that kind of accounting programme,” the pro-Vice Chancellor  informed while praising him for his support of the UWI through, among other things, his efforts to organize and facilitate the visits and meetings. Professor Shirley also announced that beginning 2013, Mr. Willie will sponsor three lectures being to be delivered at the UWI’s Department of Business, while suggested that they should, fittingly, be named in his honour. The Pro Vice Chancellor also advised that efforts are being made to secure accreditation from the Association to Advance Collegiate Schools of Business (AACSB) for the MSBM’s programmes Founded in 1916, the Washington, D.C.-based AACSB is one of the premier accreditation bodies globally for tertiary institutions offering degrees in business and accounting. In his remarks at the function, Jamaica’s Ambassador to the United States, His Excellency Stephen Vasciannie, described the proposed collaboration by the universities as a “step in the right direction”. He said the shared knowledge and experiences will enhance the learning experience at the three institutions. He also lauded Mr. Willie for his “steadfast commitment” to education at the UWI, as well as his support consistently given to various Jamaican and Caribbean projects throughout the Washington, D.C. area. In their remarks, Deans of Howard and the American Universities, Drs. Barron Harvey and Michael Ginzberg, welcomed the proposed collaborations, noting that students and lecturers would benefit significantly, particularly through exchange visits facilitated. For his part, Mr. Willie underscored his commitment to doing everything possible to support the advancement of education in Jamaica, “especially at the University of the West Indies.” RelatedUWI to Forge Stronger Links With American Universities UWI to Forge Stronger Links With American Universities EducationDecember 10, 2012 RelatedUWI to Forge Stronger Links With American Universitiescenter_img RelatedUWI to Forge Stronger Links With American Universities Advertisementslast_img read more